This is the authors' abstract. We don't add key points for this paper.
The live attenuated SA14‐14‐2 Japanese encephalitis (JE) vaccine is a historical vaccine that protects against JE. Despite its extensive use, the mechanism of protective immunity conferred by the SA14‐14‐2 vaccine is not well established. Here, we used mouse models to understand the mechanism of the development of humoral immunity against the vaccine. The vaccine induces robust GC responses within a week postimmunization. In lethal virus challenge, we show that CD4 + T cells alone, but not CD8 + T cells, are sufficient to confer vaccine‐mediated protection. However, the CD4‐mediated protection was potentiated in the presence of vaccine‐primed CD8 + T cells. Employing CD8‐deficient mice, we show that both the protective traits of CD4 + T cells and the quality of antibody response to the vaccine are impaired in absence of CD8 + T cells. We further demonstrate that the poor protective immune response induced by the vaccine in absence of CD8 + T cells is mainly due to the impaired differentiation and function of follicular Th cells, leading to suboptimal GC reaction. Our study highlights an unprecedented role of CD8 + T cells in the establishment of humoral responses to the vaccine. By elucidating underlying cellular determinants of vaccine‐induced protective immunity, our work has implications for rational design of vaccines against JE virus and related flaviviruses.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kalia et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: